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ABSTRACT
LORRAL KANAUSS: The Effect of AGE Concentration and Glucose Levels in RAGEMediated Cardiac Fibroblast Migration in Type 2 Diabetes
(Under the direction of Dr. James Stewart)
Diabetes is one of the largest health concerns in the United States. Its continuous increase
in prevalence has led to it being one of the largest healthcare costs and consistently listed as one
of the leading causes of death. That being said, diabetes also increases the risk of other health
conditions, one of which is cardiovascular disease. Left ventricle hypertrophy resulting in the
stiffening of the left ventricle and diastolic dysfunction is one form of cardiovascular disease
associated with diabetes. Thought to be impacted by decreased fibroblast migration in the
extracellular matrix, the experiments performed in this study seek to review components
believed to influence migration including the AGE/RAGE signaling cascade and glucose media
concentration. Using cardiac fibroblasts isolated from diabetic and non-diabetic mice with an
intact AGE/RAGE cascade as well as diabetic and non-diabetic mice with an impaired
AGE/RAGE cascade the number of migrated fibroblasts was totaled with varying amounts of
AGE and glucose concentration. The results of the study showed that diabetic RAGE knockout
cells had the greatest number of migrated fibroblasts, migration increased as AGE volumes
increased, and that glucose media concentration had no impact on fibroblast migration. This
signifies that the AGE/RAGE cascade does influence the migration of fibroblasts. Furthermore,
it appears as though cardiac tissue isolated from various genotypes maintain their in vivo
qualities when cultured using different concentrations of glucose.
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CHAPTER I: INTRODUCTION
Type 1 and Type 2 Diabetes Mellitus
Diabetes mellitus has a large impact on public health as 37.3 million Americans were
reported to have diabetes, and as many as 96 million individuals have prediabetes resulting in
diabetes being listed as the 8th leading cause of death in 2020 (Centers for Disease Control and
Prevention, 2022; Murphy et al., 2021). Characterized by hyperglycemia due to insufficient
insulin levels, a hormone produced by the β-cells of the pancreas or insulin resistance diabetes
mellitus can be broken down into two types. Type 1 diabetes, which are approximately 5%-10%
of cases, is found in individuals with autoimmune destruction of the β-cells of the pancreas
resulting in an insulin-secreting deficiency. Type 2 diabetes, which are 90%-95% of cases, is
linked to a genetic predisposition and/or unhealthy lifestyle factors such as obesity and lack of
physical activity. Type 2 diabetes encompasses individuals displaying insulin resistance and
potentially insulin secretory dysfunction (Oxford University Press, 2004; Deshpande et al.,
2008). Insulin resistance occurs as the result of the desensitization of insulin response. Prolonged
physiological stimuli, such as increased serum glucose concentrations, decrease pancreatic βcells secretory response (Rustenbeck, 2002). A consequence of long-term insulin resistance is βcell exhaustion in which the pancreas is no longer able to release insulin despite hyperglycemic
blood concentrations (Rustenbeck, 2002; Deshpande et al., 2008). Over time, type 2 diabetes can
lead to serious complications at both the micro and macrovascular level. The microvascular level
includes conditions such as neuropathy, nephropathy, and retinopathy while the macrovascular
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level consists of cardiovascular disease (CVD), stroke, and peripheral vascular disease
(Deshpande et al., 2008).
Diabetes and Cardiovascular Disease
Individuals with diabetes mellitus are at an increased risk of developing cardiovascular
disease (CVD). With a 2-to-4-time greater chance of cardiovascular disease-related mortality,
approximately 65% of all individuals with diabetes die as a result of CVD (Deshpande et al.,
2008). While cardiovascular disease encompasses many different types of heart disease,
cardiomyopathy is of key interest in the experiments performed for this study. Diabetesassociated cardiomyopathy refers to abnormal cardiac structure and function in individuals
without other forms of cardiovascular disease. CVD is characterized by two stages: 1) the early
stage consists of left ventricular hypertrophy and diastolic dysfunction and 2) the late-stage
displays cardiac fibrosis and systolic dysfunction (Paolillo et al., 2019). Left ventricular
hypertrophy involves the thickening of the left ventricle resulting in stiffness and incomplete
relaxation of the ventricle (Störk et al., 1995). In turn, there is a reduction in blood volume
output, the potential for pulmonary congestion, and possible heart failure (Satpathy et al., 2006).
Thought to be the result of cardiac fibrosis, a common complication of diabetes, there is an
increase in the accumulation of extracellular matrix (ECM) within tissues. Studies indicate that
diabetic tissue, free of CVD risk factors, had a significant increase in the transformation of
fibroblasts to myofibroblasts which have increased collagen production and motility to
contribute to the formation of cardiac tissue fibrosis (Fowlkes et al., 2013).
Extracellular Matrix Remodeling and Fibroblast Migration
The extracellular matrix (ECM) is composed of water, proteins, and polysaccharides and
plays a vital role in maintaining cellular structure and communication via signaling and receptor
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interactions (de Haas et al., 2014; Frantz et al., 2010). Essential proteins in the ECM include
elastin, fibronectin, and collagen which collectively provide strength, flexibility, motility, and
capability for cellular attachment. These proteins are secreted and organized by fibroblasts into a
network of fibers that allow healthy cells to resist physiological stressors and maintain the
integrity of the ECM through constant remodeling (Frantz et al., 2010). When injury occurs
growth factors, cytokines, MMPs (matrix metalloproteases), and their counterpart TIMPs (tissue
inhibitors of metalloproteases) are secreted to promote wound healing through stimulation of
fibroblast proliferation and migration (Fan et al., 2012; Frantz et al., 2010). Within the
myocardium, fibroblasts differentiate into myofibroblasts to remodel the ECM through protein
synthesis (Darby et al., 2014; Fan et al., 2012). This process results in an increased production of
collagen ultimately leading to fibrosis of the ECM (Fan et al., 2012). Individuals with diabetes
have been clinically shown to have impaired wound healing (Lerman et al., 2010). While the
complete mechanism is not fully understood, studies have shown that diabetic tissues display
decreased migration of fibroblasts and increased migration of myofibroblasts (Lerman et al.,
2010; Shamhart et al., 2014; Straino et al., 2015). The increase in myofibroblasts suggested that
increased fibroblasts differentiation in hyperglycemic conditions stimulated the production of
collagen and the hypertrophy seen in diabetic cardiomyopathy (Burr et al., 2020, Shamhart et al.,
2014).
AGE/RAGE Cascade
AGEs, advanced glycation end products, are formed through the non-enzymatic glycation
and oxidation of proteins, nucleic acids, and lipids and act as a biomarker for the gradual
biological deterioration that occurs with aging. AGEs accumulate naturally over the course of an
individual’s life but have been observed to occur at higher concentrations in individuals with
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diabetes mellitus (Hegab et al., 2012). Serum AGE levels have been reported at 7.4 U/mL in
diabetic patients while 4.2 U/mL in non-diabetic individuals (Kilhovd et al., 1999). Studies
indicate that the accumulation of AGEs interferes with the integrity of the extracellular matrix
structure and function through crosslinking extracellular proteins and binding to RAGE (receptor
for advanced glycation end products). Through binding to RAGE, an intracellular cascade is
stimulated increasing inflammation and oxidative stress (Hegab et al., 2012; Suchal et al., 2017).
Part of this signaling cascade includes activation of the ERK1/2 (extracellular signal-regulated
kinase 1/2) pathway which promotes fibrosis of the extracellular matrix (Burr et al., 2020).
Stimulation of the AGE/RAGE cascade increases tissue fibrosis of the heart contributing to
vascular stiffness associated with diabetic cardiomyopathy (Zhao et al., 2014).
Study Goals and Hypothesis
The goals of these studies were to determine if differences in fibroblast migration existed
between four study groups: 1) non-diabetic heterozygous (db/wt), 2) diabetic (db/db), 3) nondiabetic RAGE knockout (db/wt RKO), and 4) diabetic RAGE knockout (db/dbRKO) mice, when
AGE volumes were linearly increased or when glucose media concentrations were changed (e.g.,
diabetic cells in low glucose media and non-diabetic cells in high glucose media). We
hypothesized that short-term exposures to increased AGE amounts would have a greater effect
on cardiac fibroblast migration over that of short-term changes in glucose concentrations.
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CHAPTER II: METHODS
Animal Models
Diabetic Mouse Model (db/db)
The diabetic animal model used for these experiments was 16-week-old male leptin
receptor-deficient (leptin-/-) mice (BKS.Cg-Dock7m +/+ Leprdb/J, Jackson Labs). Leptin is
responsible for alerting the mice that further food intake is unnecessary. That being said, the
nonfunctional leptin receptor resulted in a loss of communication causing the animals to continue
to eat to the point of obesity and insulin resistance, both prominent characteristics of type 2
diabetes mellitus. Each of the mice in this study had a nonfunctional leptin receptor as a result of
a G→T point mutation in the OB-R receptor. The result is the insertion of a 106 nucleotide in the
leptin receptor mRNA transcript with a stop codon. The long intracellular domain form of OB-R
is crucial to the proper function of the leptin receptor and the premature stop codon interferes
with intracellular signal transduction. Due to the OB-R isoform, the mice are severely obese
(Chen et al., 2001). By 8-weeks of age the mice had developed hyperglycemia and by 12-weeks
of age, the mice were hyperglycemic, obese, and insulin resistant. Heterozygous mice (db/wt)
were included in the experiments as they are morphologically and physiologically identical to
homozygous mice (db/db) (Gao et al., 2008).
RAGE Knockout Mouse Model (RAGE-/-)
16-week-old male RAGE knockout mice (RAGE-/-) were used for the experiments in this
study. In order to obtain a RAGE knockout model, the exons 2-7 of the encoding domain for
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RAGE were flanked by two loxP of the same orientation (Liliensiek et al., 2004). Following
exposure to the Cre recombinase (Cre), the loxP were deleted and the gene was inactivated
(Liliensiek et al., 2004; Schwenk et al., 1995). The RAGE knockout mice were bred through a
crossbreeding of heterozygous (db/wt) to produce diabetic RAGE knockout (db/dbRKO) and nondiabetic RAGE knockout (db/wt RKO) animals. The diabetic RAGE knockout had developed
hyperglycemia by 8-weeks of age and by 12-weeks of age, the mice were hyperglycemic, obese,
and insulin resistant. The heterozygous mice (db/wt RKO) were included in the study as there are
no morphological and physiological differences.
Animal Care
The mice used in all experiments were 16-week-old males. They were kept in standard
environmental conditions and consumed mouse chow and tap water ad libitum. All experiments
upheld the principles of the National Institutes of Health “Guide for the Care and Use of
Laboratory Animals,” (NIH publication No. 85-12, revised 1996), and the protocol was approved
by the University of Mississippi Health Sciences Center Animal Care and Use Committee
(protocol #20-017). CO2 anesthesia and cervical dislocation were used for primary and
secondary forms of euthanasia accordingly.
Genotyping
Tail Digestion
To genotype the mice, a 0.5 cm piece of each mouse tail was placed into a 1.5 mL
microcentrifuge tube. 250 µL of alkaline lysis consisting of 50 mM NaOH dissolved in dH 2O
was added to each 1.5 mL tube. The tails were then finely minced with scissors and digested at
95°C for 1 hour in a heat block. Following the digestion, the 1.5 mL tubes were centrifuged at
14,000 x g for 5 minutes. In new 1.5 mL microcentrifuge tubes appropriately corresponding to
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the original set, 96.4 µL of the supernatant NaOH tail solution was added to 8 mM Tris-HCl
buffer solution (pH 8.8).
Db Genotyping
Diabetic and non-diabetic mice were genotyped for the leptin receptor through a
polymerase chain reaction (PCR). A master mix was prepared consisting of 15 µL 2x Dream Taq
Hot Start Mix (Thermo Fisher), 1 µL forward primer (Db-F:
AGAACGGACACTCTTTGAAGTTTGTGT), 1 µL reverse primer (Db-R2:
GGCCACAAAATATACACTTCTCTAATAAGCTC), and 12 µL RNase-free water per each
mouse sample. 29 µL of the master mix was added to PCR tubes corresponding to each mouse
sample and 1 µL of DNA was added to the appropriate tube. PCR tubes were placed into a
thermocycler (Applied Biosystems Pro-Flex Thermocycler) and were run under the following
protocol.
Temperature

Time

Cycles

94C
94C
53C
72C

5 min
30 sec
30 sec
30 sec

X1

72C

5 min

X1

4C

Hold

X 30

Table 1. PCR Steps for db genotyping

Following the first PCR cycle, the PCR product was purified. A set of chromatography
columns were placed in 1.5 mL microcentrifuge tubes corresponding to the DNA samples. 50 µL
of binding buffer (Qiagen; Fermentas GeneJet PCR Purification Kit #K0702), 50 µL of
isopropanol, and 30 µL of PCR product are added to the chromatography column and
centrifuged (Heraeus-Thermo Centrifuge) for 60 seconds at 12,000 x g. The solution that flowed
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through the filter was discarded and 700 µL of wash buffer is added to the chromatography
column. The 1.5 mL tubes are then centrifuged 2x for 60 seconds at 12,000 x g. Following the
second centrifuge cycle, the product that moved through the filter was discarded and the
chromatography column was placed into a new 1.5 mL tube. 50 µL of elution buffer (Qiagen;
Fermentas GeneJet PCR Purification Kit #K0702) was added to the column and the tubes were
centrifuged for 60 seconds at 12,000 x g.
A second PCR cycle was prepared using the final DNA product of the purification step.
A master mix was prepared consisting of 15 µL of 2x Dream Taq Hot Start Mix, 1 µL of forward
primer (Db-F: AGAACGGACACTCTTTGAAGTTTGTGT), 1 µL of reverse primer (Db-R1:
CATTCAAACCATAGTTTAGGTTTGTGT), and 12.5 µL of RNase-free water per each DNA
sample. 29.5 µL of the master mix were added to new corresponding PCR tubes and 2 µL of the
DNA product remaining from the purification step were added to the proper matching PCR tube.
The PCR tubes were then placed in the thermocycler and run under the same PCR setting as the
first PCR reaction (table 1).
Following the second PCR cycle, the DNA product was digested. A master mix was
prepared consisting of 1.5 µL of 10X Tango Yellow Buffer (Thermo Fisher), 1.5 µL of RsaI (10
U/L, Thermo Fisher), and 3.5 µL of RNase-free water per DNA sample. 6.5 µL of the master
mix was added to new corresponding PCR tubes along with 8.5 µL of the DNA product from the
second PCR reaction. The tubes were then placed into the thermocycler and run for 6 hours at
37°C. During this period, the RsaI restriction enzyme identifies the GT^AC sites and cleaves the
DNA product from the second PCR reaction.
A 3% agarose gel was made containing 1.5 g of agarose powder and 50 mL of Trisacetate-EDTA (TAE) (Thermo Fisher). The flask holding the agarose powder and TAE was
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heated until the powder was fully dissolved in the solution. 8.5 µL of ethidium bromide was
added to the solution and the solution was poured into a gel electrophoresis tray. A 15-prong gel
comb was placed into the tray, and the gel was allowed to polymerize at room temperature. After
polymerization, 3 µL of 6x dye was added to the 15 µL of digested DNA and 17 µL of the
DNA/dye mix was pipetted into the wells of the agarose gel. The gel was then run at 100 V for
60 minutes. Following the 60 minutes, the gel was visualized for the leptin receptor. A 135 bp
band indicates a knockout (leptin-/-) mouse while a 187 bp band represents a wildtype (leptin+/+)
mouse. Both a 135 bp and 187 bp band indicates a heterozygous (leptin+/-) mouse.
RAGE genotyping
To detect the RAGE receptor in diabetic and non-diabetic mice a master mix was made
consisting of 15 µL 2x Dream Taq Hot Start Mix (Thermo Fisher), 1 µL of forward primer
(mRAGE e3-F: CACAGGAAGAACTGAAGCTTGGAAGG), 1 µL of reverse primer (mRAGE
e5-R: CACCTTTGCCATCGGGAATCAGAAG), and 14 µL of RNase-free water per each DNA
sample. 31 µL of the master mix was added to new corresponding PCR tubes along with 1 µL of
DNA. The PCR tubes were placed into the thermocycler and run under the programmed setting
listed in the table below.
Temperature

Time

Cycles

94C

5 min

X1

94C

30 sec

X 30

53C

30 sec

72C

30 sec

72C

5 min

4C

Hold

X1

Table 2. PCR steps for RAGE genotyping
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Once the PCR cycle finished a 1% agarose gel was made consisting of 0.5 g of agarose
powder (Thermo Fisher) and 50 mL of TAE (Thermo Fisher). The agarose powder and TAE
were heated until the powder had completely dissolved in solution. 8.5 µL of ethidium bromide
was added, and the solution was poured into a gel electrophoresis tray. A 15-prong gel comb was
added to the electrophoresis tray and the gel was allowed to polymerize. Once polymerized 3 µL
of 6x dye was added to the DNA product of the PCR cycle. 17 µL of the DNA/dye mixture was
pipetted into each well, and the gel was run at 100 V for 20 minutes. Following 20 minutes, the
gel was visualized for the RAGE receptor. A 650 bp band indicated the RAGE receptor was
present and the mouse was wildtype (RAGE+/+), and the presence of both bands indicated a
heterozygous (RAGE+/-) mouse.
In addition to genotyping for the RAGE receptor, an internal control test was preformed
to verify the integrity of the RAGE mice to detect the presence of an enhanced green fluorescent
protein (EGFP), which was inserted in the place of the RAGE receptor of knockout mice. A
master mix was made comprising of 15 µL 2x Dream Taq Hot Start Mix (Thermo Fisher), 1 µL
of forward primer at 50 µM (EGFP36-54: GGTGCCCATCCTGGTCGAG), 1 µL of reverse
primer at 50 µM (EGFP346-328: CGAACTTCACCTCGGCGCG), and 14 µL of RNase-free
water per each DNA sample. 31 µL of the master mix was added to corresponding PCR tubes in
addition to 1 µL of DNA. The PCR tubes were placed into the thermocycler and run at the
programmed setting listed in the following table.
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Temperature
94C

Time
5 min

94C
56C
72C
72C
4C

30 sec
30 sec
45 sec
10 min
Hold

Cycles
X1
X 35
X1

Table 3. PCR steps for EGFP genotyping

After the completion of the EGFP PCR cycle a 1% agarose gel was made of 0.5 g of
agarose powder (Thermo Fisher) and 50 mL of TAE (Thermo Fisher). The agarose powder and
TAE were heated until the powder had dissolved completely into the solution. 8.5 µL of
ethidium bromide was added to the solution and it was poured into an electrophoresis tray. A 15prong gel comb was added to the tray, and the gel was left to polymerize. 3 µL of 6x dye was
added to the PCR product before 17 µL of the dye/DNA mixture was added to each well to run at
100 V for 30 minutes. The gel was then visualized for EGFP. Presence of a 310 bp band
indicates a homozygous RAGE knockout (RAGE -/-) mouse.
Fibroblast Isolation and Cell Culture
To carry out the fibroblast cell isolation the mice were euthanized with carbon dioxide
gas in addition to cervical dislocation. Each mouse’s tag number, body weight, and blood
glucose level were recorded. To obtain the blood glucose level approximately 1 cm of the
mouse’s tail was clipped off and a drop of blood was placed onto a test strip (test strips; One
Touch Ultra®, LifeScan, Inc., Johnson & Johnson) (glucometer; OneTouch Ultra®, LifeScan,
Inc., Johnson & Johnson). The mouse was then dipped in 70% ethanol for sterilization and
pinned to a dissection mat before the chest cavity was opened. The heart was removed from the
chest cavity and the weight was recorded. The heart was placed into a conical tube with 1x non-
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sterile PBS, composed of 17 mM NaCl, 0.3 mM KCl, 1.01 mM Na 2HPO4, and 0.18 mM KH2PO4
at a pH of 7.4, and placed on ice. Approximately 2-3 hearts per genotype were used for each
fibroblast isolation.
In a sterile hood, the hearts were placed in a 60 mm petri dish and finely minced. The
hearts were then washed 3x with 1x sterile PBS. After removing the final wash, 5 mL of
collagenase-trypsin enzymatic solution (0.1% Trypsin, Gibco; 100U/mL collagenase II,
Worthington Biochemical) was added to the tissue. The heart tissue and collagenase solution
were placed into a double-jacketed spinner flask with a magnetic stir bar and a continuous flow
of 37C water was maintained to optimize digestion conditions. The tissue was stirred for 10
minutes in the collagenase solution before being removed with a transfer pipette and filtered into
a 50 mL conical tube through a 100 µm sterile disposable cell filter. The tissue remaining in the
filter was pipetted back into the spinner flask and 5 mL of collagenase solution was added before
allowing the tissue to spin for an additional 10 minutes. In the 50 mL conical tube, 5 mL of
“Stop” medium (high glucose media; Dulbecco’s Modified Eagles Medium (DMEM) containing
4.5 g/L glucose, sodium pyruvate, L-glutamine, and supplemented with 14. 2mM NaHCO3, 14.9
mM HEPES, 30% heat-inactivated fetal bovine serum (FBS), 1% L-glutamine, and 0.02%
PrimocinTM (Thermo Fisher)) was added. The conical tube was then centrifuged for 10 minutes
at 170 x g. After the 10 minutes, the supernatant was removed and the pelleted cells
concentrating the bottom of the conical tube were resuspended in a Dulbecco’s Modified Eagles
Medium (DMEM) high glucose media including 15% fetal bovine serum (FBS) and incubated at
37C until additional heart tissue was added. Digestion cycles were repeated until there was no
remaining heart tissue.
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Following the completion of all cycles, the 50 mL conical tube of stock cells was
centrifuged for 10 minutes at 170 x g and the cells were resuspended with 15% FBS high glucose
media. The cells were moved from the 50 mL conical tube placed into 60 mm petri dishes with 3
mL of the stock cell solution being distributed in each dish and stored in a CO2 incubator at 37C
for 24 hours. After 24 hours the cells were washed 3x with appropriate media; non-diabetic cells
received a 15% FBS low glucose DMEM media (1 g glucose/L) and diabetic cells received a 15
% FBS high glucose DMEM media (4.5 g glucose/L). Appropriate media was then added to each
petri dish and cells were stored at 37C until ideal growth was achieved with media being
changed every other day. Visual analysis was used to determine when cells were ready to be split
into 48 well cell culture plates for the migration assay. All experiments were performed using P1
cells and 95% confluency among the cells was maintained as the optimal point for splitting.
Upon reaching 95% confluency the cells were split using a 0.25% trypsin, 0.1%
ethylenediaminetetraacetic acid (trypsin/EDTA) solution (Life Technology) into 48 well plates
and stored in a CO2 incubator at 37C. Media was removed every other day and replaced with
new media with appropriate glucose concentrations.
Migration Assay
On the bottom of the 48 well cell culture plates, a line was drawn vertically down the
center with three horizontal hashes to be used as a reference for imaging. P1 fibroblast cells were
placed into the migration plates in cells A1-A7, B1-B7, and D1-D4 with appropriate 15% FBS
media. The migration plate was then stored in a CO2 incubator at 37C until the cells reached
95% confluency. The media on the cells was removed and replaced with appropriate 15% FBS
media every other day until confluency was achieved. Once the cells reached 95% confluency
the media was removed, and the well was scratched vertically down the center with a 200 µL
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pipette tip. The cells were washed with appropriate 1.5% FBS media and 500 µL of appropriate
1.5% FBS media was added to wells A1-A7 and B1-B7. 1.5% FBS low glucose media was
added to D1 and D2 while 1.5% FBS high glucose media was added to D3 and D4. Varying
volumes of AGEs were added to the following wells as described in the following table.

Well Numbers

AGE Amount

A1 & B1

0 µL

A2 & B2

3.75 µL

A3 & B3

7.5 µL

A4 & B4

15 µL

A5 & B5

30 µL

A6 & B6

45 µL

A7 & B7

60 µL

Table 4. Amount of AGE in each well

Imaging
After preparation of the migration plate, 0-hour images were taken using a Zeiss Primovert
microscope with a camera (Zen Blue 2.3 edition, Zeiss). Two photos of each well were taken
with the first image being of the top half of the well and the second of the bottom half of the
well. The horizontal hashmarks on the bottom of the plate were used as a reference point and
there was no overlap of space between the photos taken. The plate was then placed in a CO 2
incubator at 37C for 24 hours.
Once 24 hours had passed the plate was removed from the incubator and fixed before 24hour images were taken. The media was removed from each of the wells and a 4%
paraformaldehyde (PFA) fixative was added to each well. The cell culture plate was then rocked
in a fume hood for 10 minutes before removing the PFA. The cells were washed with a 1x non-
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sterile PBS and a 0.1% Triton solution consisting of 1X PBS and Triton-100 (Thermo Fisher)
was added for permeabilization. The plate was placed back into the fume hood and allowed to
rock for 30 minutes. Directly after the 30 minutes the 0.1% Triton solution was removed and the
cells were washed with 1X non-sterile PBS before a 1% Brilliant Blue Coomassie stain (3 g
Coomassie Brilliant Blue, 45% methanol (450 mL), 10% acetic acid (100 mL), and 45% dH20
(450 mL)) was added to each well. The plate was rocked for 10 minutes in the fume hood, the
1% Coomassie stain was removed, and the cells were washed with 1X non-sterile PBS. 24-hour
images were then taken. Each well was aligned to match its 0-hour counterpart using the location
and position of the hashmarks.
Imaging Analysis
Adobe Photoshop Elements 2021 was used to superimpose the images. The 0-hour picture
was pulled up and a blank layer was placed on top. On the new layer, an outline of the scratch
line was drawn by getting the line as close to the start of the cells as possible without touching
any of the cells. The 24-hour image was then placed over the top of the 0-hour picture by varying
the transparency of the image and matching the vertical and horizontal reference point lines. The
0-hour image was removed and the layer outlining the scratch line was placed on top of the 24hour image to view the area of migration. The number of cells that had migrated into the scratch
line was counted and recorded. The area of the scratch line was then filled in and ImageJ was
used to determine the area of the scratch line. The migration data was normalized by dividing the
number of migrated cells by the area of the scratch line. The normalized data of the well’s two
images were summed to find the total number of migrated cells per area for the entire well. An
average of the wells with corresponding AGE amounts (A1-A7 and B1-B7) was calculated while
the wells with corresponding media concentrations (D1-D4) were averaged (Burr, 2020).
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Figure 1. Imaging analysis overview. Image A: On the 0-hour picture a blank layer was placed
overtop and an outline of the scratch line was drawn. Image B: The 0-hour image was placed on top
of the 24-hour picture and aligned to match. The 0-hour image was then removed, and the layer with
the scratch line was placed over top of the 24-hour image. Image C: The scratch line was filled in
and the 24-hour image was removed to determine the percent area of migration space available. All
images were taken at the 4x objective.

Statistical Analysis
The differences of various AGE amounts on cell migration in diabetic (db), non-diabetic (het),
diabetic RAGE knockout (dbRKO), and non-diabetic RAGE knockout (hetRKO) mice was
found using a two-way ANOVA Dunnett’s Post Hoc analysis. The effect of varying glucose
media concentrations on cell migration was established using a one-way ANOVA Tukey Post
Hoc analysis. A p<0.05 was used to define significance and error bars represent ± standard error
of the mean (SEM).
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CHAPTER III: RESULTS
Mice Physiology
Body Weights
Non-diabetic mice and non-diabetic RAGE knockout mice had comparable body weights
with an average weight of 28.1 g and 29.9 g, respectively, with no significance between the two
groups. Likewise, diabetic mice and diabetic RAGE knockout mice had an average body weight
of 54.1 g and 54.2 g, respectively, with no statistical significance between diabetic groups.
Statistical significance was observed between non-diabetic mice and both diabetic and diabetic
RAGE knockout mice. Furthermore, there was also significance between non-diabetic RAGE
knockout mice and both diabetic and diabetic RAGE knockout mice, shown in Figure 2.
Ventricular Weights
All mice genotypes had similar ventricular weights and no statistical significance was
found between any of the four genotypes, as shown in Figure 2. The average heart weight of
non-diabetic mice was 0.15 g and non-diabetic RAGE knockout hearts averaged at 0.12 g. The
mean heart weight of diabetic mice was 0.12 g and the diabetic RAGE knockout mice had an
average heart weight of 0.12 g.
Blood Glucose Concentrations
Non-diabetic mice and non-diabetic RAGE knockout mice had comparable blood glucose
concentrations. Non-diabetic mice had an average blood glucose concentration of 216.9 mg/dL
and non-diabetic RAGE knockout mice had an average blood sugar of 195.5 mg/dL with no
statistical significance between the two groups. Diabetic and diabetic RAGE knockout mice also
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had comparable and statistically not significant blood glucose concentrations with an average of
445.5 mg/dL and 422.6 mg/dL respectively. There was statistical significance between nondiabetic mice and both diabetic mice and diabetic RAGE knockout mice as well as between nondiabetic RAGE knockout mice and both diabetic and diabetic RAGE knockout mice, as
displayed in Figure 2.
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Figure 2: Physiology data of all mice genotypes. Bodyweight, ventricular weight, and blood glucose
concentration was recorded for all mice used in the experiments. Diabetic (db) and diabetic RAGE
knockout (dbRKO) mice had no statistical significance between body weight and blood glucose.
Similarly, non-diabetic (het) and non-diabetic RAGE knockout (hetRKO) mice had no significance
between bodyweight and blood glucose. Significance was observed between non-diabetic (het) and
both diabetic (db) and diabetic RAGE knockout (dbRKO) mice for body weight and blood glucose.
Significance was also observed between non-diabetic RAGE knockout (hetRKO) and both diabetic
(db) and diabetic RAGE knockout (dbRKO) mice for body weight and blood glucose. No significance
was found for ventricular weights among any of the genotypes. Bars represent mean ± SEM.
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Cardiac Fibroblast Migration with Varying AGE Amounts
A two-way ANOVA with a Dunnett’s Post Hoc analysis were utilized to determine the
significance between various AGE amounts added to the four genotypes and the number of
migrated cells per percent area. Results are displayed in Figure 3 listed below. Overall, each
genotype displayed an increasing number of migrated cells as the AGE volumes increased.
Diabetic cells migrated more than their non-diabetic counterpart, and diabetic RAGE knockout
fibroblast migrated more than non-diabetic RAGE knockout cells. Overall, diabetic RAGE
knockout mice demonstrated the most migration out of any of the four genotypes. In comparison
to the three remaining genotypes (db, het, and hetRKO), diabetic RAGE knockout cells migrated
more per percent area at all AGE volumes with a statistical significance of p<0.05 reported. This
finding is consistent with the previous findings in that the AGE/RAGE cascade impacts
fibroblast migration in diabetic cells (Burr et al., 2020; Hegab et al., 2012). The second-largest
cellular migration was in the diabetic genotype. Significance was observed between the
migration of diabetic cells and both non-diabetic cells and non-diabetic RAGE knockout cells at
AGE amounts of 7.5 µL, 30 µL, 45 µL, and 60 µL. Non-diabetic fibroblasts migrated more than
non-diabetic RAGE knockout cells with a significance of p<0.05 occurring at AGE amounts of 0
µL, 3.75 µL, 30 µL, and 60 µL.
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Figure 3: Overview of the number of migrated cells per percent area for all genotypes.
Diabetic RAGE knockout cells displayed the most cellular migration at all AGE
concentrations. Significance was observed between dbRKO migration and the migration of
all other genotypes at each AGE concentration. Diabetic fibroblasts had the second largest
migration with significance found between non-diabetic and non-diabetic RAGE knockout
cells at AGE concentrations of 7.5 µL, 30 µL, 45 µL, and 60 µL. Non-diabetic RAGE
knockout cells migrated the least of the four genotypes with significance being reported to
non-diabetic cells at 0 µL and 3.75 µL of AGE concentration. Bars represent mean ± SEM.
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Cardiac Fibroblast Migration with 0 µL of added AGE
A one-way ANOVA with a Tukey’s Post Hoc analysis were used to determine
significance between genotype and the number of migrated cells per percent area. Migration
assays were performed using all genotypes and 0 µL of added AGE with the results documented
in Figure 4. Diabetic RAGE knockout cells demonstrated the most migration per percent area
with a statistical significance of p<0.05 to all other genotypes (db, het, and hetRKO). Nondiabetic and diabetic cells displayed similar migration patterns with both hovering around 5 cells
migrated per percent area and no statistical significance between the two. Non-diabetic RAGE
knockout cells migrated the least with a statistical significance of p<0.05 to non-diabetic cells.
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Figure 4. Cardiac fibroblast migration with
0 µL of added AGE. Diabetic RAGE knockout
(dbRKO) cells had the largest number of
fibroblasts migrate per percent area.
Significance was found between dbRKO and all
other genotypes with a p<0.05. Non-diabetic
(het) cells had the second largest number of
migrated cells with a significance to nondiabetic RAGE knockout (hetRKO) cells. There
was no significance reported between diabetic
(db) and hetRKO cells. Bars represent mean ±
SEM. *p<0.05.
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Cardiac Fibroblast Migration with 3.75 µL of added AGE
Using a one-way ANOVA with a Tukey’s Post Hoc analysis, migration assays were
analyzed using all genotypes and 3.75 µL of added AGE with the results documented in Figure
5. Diabetic RAGE knockout cells migrated the most per percent area and showed statistical
significance with a p<0.05 to all other genotypes (db, het, and hetRKO). The remaining three
genotypes had no significance in migration between each other.
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Figure 5. Cardiac fibroblast migration with
3.75 µL of added AGE. Diabetic RAGE
knockout (dbRKO) fibroblasts displayed the
most cellular migration per percent area.
Significance of p<0.05 was recorded between
dbRKO cells and all other genotypes. No
significance in cell migration number was
determined between any of the remaining of
the remaining genotypes. Bars represent mean
± SEM. *p<0.05.
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Cardiac Fibroblast Migration with 7.5 µL of added AGE
Migration assays were performed using all genotypes and 7.5 µL of added AGE with the
results documented in Figure 6. Diabetic RAGE knockout cells displayed the most migration of
the genotypes as measured by a one-way ANOVA with a Tukey’s Post Hoc analysis.
Significance was found between diabetic RAGE knockout cells and all remaining genotypes with
a p<0.05. Diabetic cells displayed the second greatest number of migration and were statistically
significant to both non-diabetic and non-diabetic RAGE knockout cells. Non-diabetic and nondiabetic RAGE knockout genotypes had similar cell migration numbers hovering around 2
migrated fibroblasts per percent area with no significance reported between the two groups.
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Figure 6. Cardiac fibroblast migration
with 7.5 µL of added AGE. Diabetic RAGE
knockout (dbRKO) cells displayed the
greatest fibroblast migration per percent area
with a significance of p<0.05 to all
genotypes. Diabetic (db) cells exhibited the
second greatest migration showing
significance to non-diabetic (het) and nondiabetic RAGE knockout (hetRKO)
fibroblasts. No significance was observed
between the migration of het and hetRKO
cells. Bars represent mean ± SEM. *p<0.05.
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Cardiac Fibroblast Migration with 15 µL of added AGE
Migration assays were performed using all genotypes and 15 µL of added AGE and
analyzed using a one-way ANOVA with a Tukey’s Post Hoc analysis. The results are
documented in Figure 7 below. Diabetic RAGE knockout cells migrated the most per percent
area and showed statistical significance with a p<0.05 to all other genotypes (db, het, and
hetRKO). The remaining three genotypes had no significance in migration between each other.
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Figure 7. Cardiac fibroblast migration with
15 µL of added AGE. Diabetic RAGE knockout
(dbRKO) cells migrated more than any other
genotype. Significance of p<0.05 was reported
between dbRKO fibroblasts and all other
genotypes. No significance was shown between
any of the remining genotypes. Bars represent
mean ± SEM. *p<0.05.
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Cardiac Fibroblast Migration with 30 µL of added AGE
Migration assays including all genotypes and 30 µL of added AGE were analyzed using a
one-way ANOVA test with a Tukey’s Post Hoc analysis. The results are documented below in
Figure 8. Diabetic RAGE knockout cells had the greatest number of migrated cells per percent
area of all genotypes. A significance of p<0.05 was reported between diabetic RAGE knockout
cells and all genotypes. Diabetic fibroblasts had the second greatest number of migrated cells
with significance to non-diabetic RAGE knockout cells. No significance was indicated between
diabetic and non-diabetic cell migration. Similarly, no significant difference in fibroblast
migration was specified between non-diabetic and non-diabetic RAGE knockout cells.
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Figure 8. Cardiac fibroblast migration
with 30 µL of added AGE. Diabetic RAGE
knockout (dbRKO) cells demonstrated the
greatest number of migrated fibroblasts per
percent area with a significance of p<0.05 to
all genotypes. Diabetic (db) fibroblasts
displayed a significance to non-diabetic
RAGE knockout (hetRKO) cells. No
significance was found between the
migration of non-diabetic (het) cells and
hetRKO cells. Bars represent mean ± SEM.
*p<0.05.
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Cardiac Fibroblast Migration with 45 µL of added AGE
All genotypes were included in the migration assays with 45 µL of added AGE and the
results were analyzed using a one-way ANOVA with a Tukey’s Post Hoc analysis. The results
are documented below in Figure 9. Diabetic RAGE knockout fibroblasts demonstrated the most
cellular migration and reported statistical significance between all three genotypes with a p<0.05.
There was no significant migration observed in any of the remaining genotypes.

32

Figure 9. Cardiac fibroblast migration
with 45 µL of added AGE. Diabetic
RAGE knockout (dbRKO) fibroblasts
displayed the most cellular migration and
reported significance of p<0.05 to all
genotypes. No significance was observed
between any other genotypes. Bars
represent mean ± SEM. *p<0.05.
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Cardiac Fibroblast Migration with 60 µL of added AGE
Migration assays were performed using all genotypes and 60 µL of added AGE with the
results documented in Figure 10. Utilizing a one-way ANOVA with a Tukey’s Post Hoc analysis
to analyze the findings it was reported that diabetic RAGE knockout fibroblasts displayed the
most migration per percent area with a significance of p<0.05 to all genotypes. Diabetic
fibroblasts had the second largest number of cells migrate per percent are with significance
reported to non-diabetic and non-diabetic RAGE knockout cells. No significance was found
between non-diabetic and non-diabetic RAGE knockout fibroblast migration.
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Figure 10. Cardiac fibroblast migration
with 60 µL of added AGE. Diabetic RAGE
knockout (dbRKO) fibroblasts demonstrated
the greatest migration per percent area with a
significance of p<0.05 to all genotypes.
Diabetic (db) fibroblasts had the second largest
migration with significance observed to both
non-diabetic (het) and non-diabetic RAGE
knockout (hetRKO) cells. There was no
significance reported between het and hetRKO
cells. Bars represent mean ± SEM. *p<0.05.
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Cardiac Fibroblast Migration with Varying Glucose Media Concentration
Migration assays comparing the impact glucose media concentration has on fibroblast
migration were performed on all genotypes and the results are shown in Figure 12. A two-way
ANOVA and Dunnett Post Hoc analysis were used to interpret the relationship. Each migration
plate included two wells treated with a 1.5% low glucose media and two wells treat with a 15%
high glucose media. The results of the experiment indicate that there is no statistical significance
between glucose media concentration. All genotypes had a comparable number of migrated cells
per percent area resulting in no statistical significance between glucose media concentrations.
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Figure 11. Images of migration with varying media concentration. A
migration assay comparing the impact of glucose media concentration was
carried out with all genotypes. A 1.5% glucose FBS media was used for a low
glucose concentration media and a 15% glucose FBS media was used the high
glucose concentration media.
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Figure 12. Cardiac fibroblast migration at varying glucose media concentration. Diabetic
RAGE knockout fibroblasts displayed the most cellular migration per percent area followed by
diabetic, non-diabetic, and non-diabetic RAGE knockout respectively. There was no significance
reported between 1.5% low glucose media and 15% high glucose media for any of the genotypes.
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CHAPTER IV: DISCUSSION
The goal of these studies was to determine if differences in cell migration existed in
fibroblasts from non-diabetic and diabetic hearts with or without RAGE when AGE volumes
were linearly increased. We also wanted to see if changes in glucose media concentrations (e.g.,
diabetic cells in low glucose media and non-diabetic cells in high glucose media) resulted in
altered cardiac fibroblast migration. We found that short-term exposures to linearly increasing
AGE amounts had a greater effect on cardiac fibroblast migration. Swapping glucose
concentrations for 24-hours did not alter cell migration, and the trends previously observed by
our lab were comparable to those observed in this study.
Cardiac Fibroblast Migration Adding Various Amounts of AGEs
Each genotype displayed an increased number of migrated cells as the amount of AGEs
increased. There appeared to be a genotype-dependent migration response discussed previously
in the results that remains consistent with the addition of various amounts of AGE. Diabetic
fibroblasts tended to migrate more than non-diabetic fibroblasts. While diabetic RAGE knockout
fibroblasts migrated more than non-diabetic RAGE knockout fibroblasts. Additionally, these
findings support the idea that as the ECM changes with additional AGEs the degree of migration
will increase as well. Ultimately, diabetic RAGE knockout cells demonstrated the most
migration with each amount of added AGEs. Past studies have shown that diabetic tissues
displayed decreased migration of fibroblasts, and that increased migration was consistent with
changes in myofibroblast phenotype switches (Lerman et al., 2010; Shamhart et al., 2014;
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Straino et al., 2015). One idea that has been proposed is AGEs will increase the differentiation of
fibroblasts to myofibroblasts, which could account for the increase in migration seen with
increased AGE amounts, particularly in diabetic cells (Burr et al., 2020; Suchal et al., 2017).
However, our findings indicated RAGE knockout cells migrated more than all other phenotypes.
Further investigation on the impact AGEs have on fibroblast differentiation would be necessary
for confirmation.
Cardiac Fibroblast Migration with Knocked Out RAGE Expression
While understanding the impact of increasing AGE amounts in the ECM, it is also key to
understand the effects of RAGE signaling on migration. The experimental results indicated
genotype greatly impacted cell migration regardless of added AGEs and varying media
concentrations of glucose. Overall, diabetic fibroblasts had a larger number of migrated cells
than non-diabetic cells. The same was true for cells without RAGE as diabetic RAGE knockout
fibroblasts migrated significantly more than non-diabetic RAGE knockout fibroblasts. Diabetic
RAGE knockout fibroblasts had significantly the largest number of migrated cells of any
genotype, and our results demonstrated RAGE knockout cells underwent significantly more
migration compared to all other genotypes. These results are consistent with previously reported
findings and provide evidence that an intact AGE/RAGE cascade results in a less motile cell
phenotype (Burr et al., 2020). Further studies will need to be performed in order to understand
the driving factors, beside AGEs, that promote the pronounced response observed in RAGE
knockout fibroblasts. Our data supports the idea that downregulation of RAGE could be valuable
in decreasing the accumulation of ECM collagen promoting left ventricle hypertrophy in
individuals with diabetes (Asif et al., 2000; Burr et al., 2020).
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Cardiac Fibroblast Migration Using Varying Glucose Media Concentration
While hyperglycemic conditions have been demonstrated to increase AGE accumulation
as well as alter migration of cells. As displayed in Figure 12, varying glucose media
concentration appears to have no significant effect on the migration of fibroblasts. Cells placed
into a 1.5% glucose concentration (low glucose or euglycemic conditions) had a comparable
number of migrated cells to those placed in 15% glucose concentration (high glucose or
hyperglycemic conditions) in a 24-hour period. This demonstrates that by varying glucose
concentrations fibroblasts will maintain their in vivo migration response. Cellular retainment of
in vivo characteristics has been observed within other studies showing the potential for a
maintained response similar to that observed in the heart in varying in vitro environments (Burr
et al., 2020; Driskell and Watt, 2014; Sorrell and Caplan, 2004; Sriram et al., 2015). Therefore, it
is possible cells continually exposed to a hyperglycemic environment could be “programmed” to
respond differently as compared to cells in a euglycemic in vivo setting.
Conclusion
The experiments performed indicate fibroblast migration is influenced by multiple
factors. Genotypic differences indicate diabetic fibroblasts migrate more than the fibroblasts of
non-diabetic tissue. Similarly, cardiac tissue with downregulated RAGE signaling shows that
diabetic RAGE knockout cells had greater migration than non-diabetic RAGE knockout. Overall,
diabetic RAGE knockout cells migrated more than all other genotypes regardless of the amount
of added AGEs. This provides support for the claim that the AGE/RAGE cascade can interfere
with fibroblast motility. A second factor that has been shown to influence fibroblast migration is
the amount of AGEs present in cardiac tissue. Fibroblast migration of all genotypes was
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increased with increasing amounts of AGEs. While it is not entirely known what the role of
AGEs are in fibroblast differentiation the data is consistent with the proposition that AGEs will
increase the transition from fibroblast to myofibroblast to increase overall migration as evident in
the diabetic cells. Lastly, it is evident that glucose concentration does not interfere with fibroblast
migration during cell culturing. With this in mind, the findings from these experiments offer
information that may be valuable to the improvement of diabetic complications. Downregulation
of the AGE/RAGE signaling cascade offers the potential to assist in the remodeling of the
extracellular matrix and reduce the damage associated with diabetic cardiomyopathy.
Future Experiments
Following these experiments, we plan on looking at the effect other proteins have on the
AGE/RAGE cascade. One such protein is Rap1a a GTPase protein belonging to the Ras
superfamily, which has demonstrated a vital role in cardiac function and remodeling (Dong et al.,
2012). Acting as a molecular switch, Rap1a has been shown to activate the ERK1/2
(extracellular signal-regulated kinase 1/2) pathway (Yan et al., 2008). As the ERK1/2 pathway is
also a component of the AGE/RAGE cascade, it appears Rap1a intersects the cascade and aids in
the promotion of tissue fibrosis associated with diabetic cardiomyopathy (Kay et al., 2016; Burr
et al., 2020). To carry out the experiment evaluating the impact Rap1a has on cardiac fibroblast
migration cardiac tissue would be isolated from wildtype (Rap1a+/+ or Rap1a+/-) mice and Rap1a
knockout (Rap-/-) and added to 48 well plates with the same varying AGE volumes used
throughout the completed experiments (0 µL, 3.75 µL, 7.5 µL, 15 µL, 30 µL, 45 µL, and 60 µL)
Following a 24 hour incubation period at 37C, the plate would be imaged and analyzed using
the same method previously outlined to find the average number of migrated fibroblasts per
percent area. Through this, the dampening effect of Rap1a on ECM fibrosis would be seen and
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potentially offer a way to downregulate the AGE/RAGE cascade without completely inhibiting it
through RAGE knockout. Testing the effect of the AGE/RAGE signaling cascade on fibroblast
function is necessary to understand the role of this cascade in diabetes.
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